Plant-based corosolic acid: Future anti-diabetic drug?

Diabetes is one of the nation’s most prevalent, debilitating and costly diseases. For diabetes, frequent insulin treatment is very expensive and may increase anti-insulin antibody production, which may cause unwanted side effects. Corosolic acid may also have some efficacy in the treatment of diabetes, but without induction of anti-insulin antibodies. Recently, corosolic acid from Lagerstroemia speciosa L. leaf extracts has been reported to act via an indirect mechanism (unlike insulin) in animal experiments. The insulin-complementary anti-diabetic therapeutic value observed in these Japanese preliminary clinical trials has led to renewed interest in the biosynthesis of this compound. So far, there has been no clear evidence for a corosolic acid biosynthetic pathway in plants. This article provides possible roles of corosolic acid and hypothetical information on the biosynthetic pathway in plants.

Plant-based corosolic acid: Future anti-diabetic drug?
banaba leaf extract

Staherb Natural Ingredients Co., Ltd main product include banaba leaf extract Corosolic acid (1-98%),Dihydromyricetin (1-98%), Euccomia Bark Extract (5-95%),
Amygdalin (50-98%),Ursolic acid (25-98%) ,myricetin(10%-98%),magnolia bark extract,rosmary leaf extract ,macleaya cordata extract ect.
Banaba leaf extract corosolic acid contact